Amgen (NQ:AMGN)

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing model.

Topics Artificial Intelligence

Trump Plans AstraZeneca Deal To Cut Drug Prices For Low-Income Americans ↗

October 10, 2025

Via Benzinga

Topics Government

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch ↗

October 09, 2025

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Via Benzinga

Topics Government

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

P/E Ratio Insights for Amgen ↗

October 03, 2025

Via Benzinga

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

October 08, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Topics Stocks

Martin Capital Buys Into Portland General Electric’s Defensive Power Play ↗

October 07, 2025

Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices ↗

Topics Energy Regulatory Compliance

October 06, 2025

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions.

Via Benzinga

Topics Government

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock ↗

October 06, 2025

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan ↗

Topics Energy

October 06, 2025

Martin Capital Exits $5.8 Million Comcast Stake as Broadband Challenges Persist ↗

October 06, 2025

Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings ↗

October 06, 2025

Patients can purchase Repatha at a discount through Amgen’s direct-to-patient program, AmgenNow.

Amgen To Sell Cholesterol Drug For Approximately 60% Discount ↗

October 06, 2025

Via Stocktwits

Topics Government

4 Reasons to Buy Amgen Stock Right Now ↗

October 04, 2025

For those with a sufficiently long investment horizon, the stock looks attractive.

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech.

Topics Intellectual Property

Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets ↗

October 03, 2025

Via Benzinga

Topics Artificial Intelligence Stocks

FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape

October 03, 2025

In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca...

U.S. Jobs Report Stalled Amidst Federal Shutdown: A Critical Information Vacuum for Markets and Policymakers

October 02, 2025

Washington D.C., October 2, 2025 – As a federal government shutdown extends into its second day, the highly anticipated U.S. Jobs Report, typically released on the first Friday of each month, has been...

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

Topics Bonds Economy

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength

Topics Artificial Intelligence Economy Stocks

October 02, 2025

Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC....

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

Topics Economy

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap ↗

October 02, 2025

Via Benzinga

Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings

October 02, 2025

Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to...

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

Topics Economy Intellectual Property Stocks

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

October 02, 2025

Check out the companies making headlines yesterday:

What's one piece of advice Dr. Bruce Beutler gives to anyone interested in excelling in science? Go outside. It worked for him.

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done ↗

October 02, 2025

Via Investor's Business Daily

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer ↗

October 02, 2025

These stocks have been raising their payouts much faster than most dividend payers.

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed...

Topics Economy

Why Are Amgen (AMGN) Shares Soaring Today

October 01, 2025

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Topics Economy Government Intellectual Property

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? ↗

October 01, 2025

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff ↗

October 01, 2025

Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.

Via Investor's Business Daily

Topics Economy Government World Trade

Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement

September 30, 2025

New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...